“…As the enlarged adenoids and tonsils consist of hypertrophied lymphoid tissue, anti-inflammatory medications may be e ective in reducing the size of adenoids and tonsils and have therefore been proposed in the past as a useful noninvasive treatment option in children with residual OSA or contraindications to surgery (Alexopoulos 2004;Goldbart 2005;Kheirandish 2006). This approach was further supported by the observation that a substantial proportion of children with OSA exhibit symptoms of allergic rhinitis (McColley 1997) or asthma (Brockmann 2014). Therefore, anti-inflammatory drugs such as corticosteroids, leukotriene receptor antagonists (e.g.…”